Non categorizzato Pfizer’s Paxlovid lowers COVID risks in over 65s Giugno 2, 2022 0 commenti The antiviral treatment developed by Pfizer Inc., Paxlovid, has been determined to reduce both hospitalization and death rates due to COVID-19 in populations older than 65 regardless of their vaccinat… About the author:
Get involved!
Comments